Balance Sheet Decomposition

Split assets against liabilities and equity, then see which groups moved from the prior period.

Sun Pharmaceutical Industries Limited · SUNPHARMA.NSE · Annual · 2026-03-31 · compared with 2025-03-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $1,087.85B − (Liabilities $249.05B + Equity $835.70B) = $3.10B · out of balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$116.03B
10.7%
$2.71B
2.4%
Assets
Receivables
$155.62B
14.3%
$25.16B
19.3%
Assets
Inventory
$114.93B
10.6%
$12.50B
12.2%
Assets
Other current assets
$42.68B
3.9%
-$788.50M
-1.8%
Assets
PPE
$124.95B
11.5%
$12.24B
10.9%
Assets
Goodwill & intangibles
$233.79B
21.5%
$54.19B
30.2%
Assets
Other
$299.84B
27.6%
$60.82B
25.4%
Liabilities + Equity
Accounts payable
$73.34B
6.8%
$11.49B
18.6%
Liabilities + Equity
Short-term debt
$42.34B
3.9%
$22.31B
111.3%
Liabilities + Equity
Other liabilities
$133.37B
12.3%
$19.11B
16.7%
Liabilities + Equity
Equity
$835.70B
77.0%
$113.52B
15.7%